Clinical Case Reports (May 2021)

Recombinant tissue‐type plasminogen activator treatment in an extremely low birth weight infant

  • Tomonori Kurimoto,
  • Yoshikazu Shimoji,
  • Atsuya Shimabukuro,
  • Tatsuo Ohshiro

DOI
https://doi.org/10.1002/ccr3.4236
Journal volume & issue
Vol. 9, no. 5
pp. n/a – n/a

Abstract

Read online

Abstract Tissue plasminogen activator can effectively treat clinical thrombosis in premature infants 11 hours after birth.

Keywords